| abstract |
The invention relates to the use of a class of compounds (I) which are squalene synthetase inhibitors in the treatment of diseases associated with undesirable cholesterol levels in the body, and particularly diseases of the cardiovascular system, such as atherosclerosis. In said formula (I), G is selected from one of the azabicyclic rings (a) or (b) wherein the thiadazole ring can be attached at any carbon atom of the azabicyclic ring. |